Northern Trust’s Coya Therapeutics COYA Stock Holding History

Northern Trust’s Portfolio COYA Stock Details COYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$159K	Hold	40,418	–	–	﹤0.01%	4004
2025 Q4	$234K	Buy	40,418 +8,097	+25%	+$49.2K	﹤0.01%	3922
2025 Q3	$184K	Sell	32,321 -7,055	-18%	-$42.9K	﹤0.01%	4008
2025 Q2	$226K	Buy	39,376 +8,197	+26%	+$47.5K	﹤0.01%	3896
2025 Q1	$202K	Buy	31,179 +2,630	+9%	+$16.7K	﹤0.01%	3942
2024 Q4	$164K	Buy	28,549 +3,099	+12%	+$21.1K	﹤0.01%	4044
2024 Q3	$164K	Hold	25,450	–	–	﹤0.01%	3942
2024 Q2	$154K	Sell	25,450 -17	-0.1%	-$137	﹤0.01%	3941
2024 Q1	$253K	Buy	25,467 +10,594	+71%	+$83K	﹤0.01%	3813
2023 Q4	$110K	Buy	+14,873	New	+$82.5K	﹤0.01%	4092

Other funds holding COYA

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Northern Trust's COYA Position: Q1 2026 in Review

Northern Trust held its Coya Therapeutics (COYA) position steady in Q1 2026 at 40,418 shares worth $159K. The position accounts for ﹤0.01% of the portfolio, ranked #4004.

Northern Trust first reported a position in COYA in Q4 2023 and has held it in 10 quarters since. The position peaked at $253K in Q1 2024. 56 funds tracked by Wall St. Rank hold COYA as of Q1 2026.

Northern Trust held 40,418 shares of Coya Therapeutics worth $159K as of Q1 2026.
Northern Trust left its Coya Therapeutics share count unchanged in Q1 2026.
Coya Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #4004 holding.
Northern Trust first reported a position in Coya Therapeutics in Q4 2023 and has held it in 10 quarters since.
Northern Trust's Coya Therapeutics position peaked at $253K in Q1 2024.
56 funds tracked by Wall St. Rank held Coya Therapeutics as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.